Sustained Scalp, Eyebrow, and Eyelash Hair Regrowth With Ritlecitinib Through Week 48 in Patients With Alopecia Areata: Post-Hoc Analysis of the ALLEGRO Phase 2b 3 Study. J of Skin 2023, 7 (6), s293. https://doi.org/10.25251/skin.7.supp.293.